scholarly article | Q13442814 |
P50 | author | Matthias Egger | Q19996372 |
Amy C Justice | Q42395670 | ||
Constantin T Yiannoutsos | Q83393956 | ||
P2093 | author name string | Maya Petersen | |
P2860 | cites work | HIV and noncommunicable cardiovascular and pulmonary diseases in low- and middle-income countries in the ART era: what we know and best directions for future research | Q26827746 |
Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysis | Q27000959 | ||
HIV, tuberculosis, and noncommunicable diseases: what is known about the costs, effects, and cost-effectiveness of integrated care? | Q27010874 | ||
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration | Q28222847 | ||
The end of AIDS: HIV infection as a chronic disease | Q28300749 | ||
Prognosis Research Strategy (PROGRESS) 3: prognostic model research | Q28709215 | ||
Profile: the Karonga Health and Demographic Surveillance System | Q28727176 | ||
Profile: Agincourt health and socio-demographic surveillance system | Q28728205 | ||
HIV, aging and continuity care: strengthening health systems to support services for noncommunicable diseases in low-income countries | Q43679820 | ||
Risk of non-AIDS-related mortality may exceed risk of AIDS-related mortality among individuals enrolling into care with CD4+ counts greater than 200 cells/mm3. | Q44203105 | ||
The Veterans Affairs Healthcare System: A unique laboratory for observational and interventional research | Q45332693 | ||
Assessing the effectiveness of antiretroviral adherence interventions. Using marginal structural models to replicate the findings of randomized controlled trials | Q46120113 | ||
Smoking among HIV positive New Yorkers: prevalence, frequency, and opportunities for cessation | Q46382491 | ||
Asymptotic optimality of likelihood-based cross-validation | Q46523230 | ||
Profile: the KEMRI/CDC Health and Demographic Surveillance System--Western Kenya | Q46587953 | ||
Super learner | Q46932589 | ||
The unseen sample in cohort studies: estimation of its size and effect. Multicenter AIDS Cohort Study | Q47421718 | ||
Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. | Q51809092 | ||
Development and verification of a "virtual" cohort using the National VA Health Information System. | Q51937405 | ||
PHosphatidylethanol (PEth) concentrations in blood are correlated to reported alcohol intake in alcohol-dependent patients. | Q51943448 | ||
Hiding in the shadows of the HIV epidemic: obesity and hypertension in a rural population with very high HIV prevalence in South Africa | Q55546962 | ||
Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study | Q56530639 | ||
Differences in cardiovascular risk factors in rural, urban and rural-to-urban migrants in Peru | Q28744385 | ||
Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond | Q29614697 | ||
Marginal structural models and causal inference in epidemiology | Q29619287 | ||
Responding to the HIV pandemic: the power of an academic medical partnership. | Q30363938 | ||
The global cardiovascular risk transition: associations of four metabolic risk factors with national income, urbanization, and Western diet in 1980 and 2008. | Q30428113 | ||
Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review | Q33302944 | ||
Sampling-based approaches to improve estimation of mortality among patient dropouts: experience from a large PEPFAR-funded program in Western Kenya | Q33388709 | ||
Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. | Q33460434 | ||
Assessing the generalizability of prognostic information | Q33540894 | ||
Systemic effects of inflammation on health during chronic HIV infection | Q33577551 | ||
Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review | Q33619740 | ||
Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan Africa | Q33803701 | ||
Correcting for mortality among patients lost to follow up on antiretroviral therapy in South Africa: a cohort analysis | Q33838306 | ||
The burden of selected chronic non-communicable diseases and their risk factors in Malawi: nationwide STEPS survey | Q33918330 | ||
Biomarker discovery using targeted maximum-likelihood estimation: application to the treatment of antiretroviral-resistant HIV infection | Q33938373 | ||
Causal effects in clinical and epidemiological studies via potential outcomes: concepts and analytical approaches | Q33960730 | ||
Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review | Q33979497 | ||
Estimating loss to follow-up in HIV-infected patients on antiretroviral therapy: the effect of the competing risk of death in Zambia and Switzerland | Q34113515 | ||
Noncommunicable diseases in HIV infection in low- and middle-income countries: gastrointestinal, hepatic, and nutritional aspects | Q34157953 | ||
HIV treatment as prevention: models, data, and questions--towards evidence-based decision-making | Q34339523 | ||
An experimental design for the development of adaptive treatment strategies | Q34374570 | ||
A systematic review of Demographic and Health Surveys: data availability and utilization for research | Q34380157 | ||
Leveraging rapid community-based HIV testing campaigns for non-communicable diseases in rural Uganda | Q34391572 | ||
Recent developments in hiv treatment and their dissemination in poor countries | Q34400513 | ||
Hypertension and obesity in adults living in a high HIV prevalence rural area in South Africa | Q34452281 | ||
Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes | Q34556854 | ||
Genes, environment and the value of prospective cohort studies | Q34567044 | ||
Tackling non-communicable diseases in low- and middle-income countries: is the evidence from high-income countries all we need? | Q34574778 | ||
Immunologic basis of cardiovascular disease in HIV-infected adults | Q34638205 | ||
Rates and factors associated with major modifications to first-line combination antiretroviral therapy: results from the Asia-Pacific region | Q34804309 | ||
An internationally generalizable risk index for mortality after one year of antiretroviral therapy. | Q34813110 | ||
Virologic and immunologic response, clinical progression, and highly active antiretroviral therapy adherence. | Q35057780 | ||
Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes | Q35111146 | ||
Prognosis of children with HIV-1 infection starting antiretroviral therapy in Southern Africa: a collaborative analysis of treatment programs | Q35148237 | ||
Global health: the Fogarty International Center, National Institutes of Health: vision and mission, programs, and accomplishments | Q35215367 | ||
The first decade of antiretroviral therapy in Africa | Q35337985 | ||
Challenges in the detection, prevention, and treatment of HIV-associated malignancies in low- and middle-income countries in Africa | Q35360144 | ||
A marginal structural model to estimate the causal effect of antidepressant medication treatment on viral suppression among homeless and marginally housed persons with HIV | Q35526694 | ||
Treatment outcomes of a stage 1 cognitive-behavioral trial to reduce alcohol use among human immunodeficiency virus-infected out-patients in western Kenya | Q35529225 | ||
Nurturing the global workforce in clinical research: the National Institutes of Health Fogarty International Clinical Scholars and Fellows Program | Q35576126 | ||
A causal framework for understanding the effect of losses to follow-up on epidemiologic analyses in clinic-based cohorts: the case of HIV-infected patients on antiretroviral therapy in Africa | Q35963111 | ||
Building capacity in health research in the developing world. | Q36006023 | ||
Optimizing randomized trial designs to distinguish which subpopulations benefit from treatment | Q36145026 | ||
HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group | Q36147395 | ||
Cohort Profile: the international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa | Q36301925 | ||
Prognosis research strategy (PROGRESS) 1: a framework for researching clinical outcomes | Q36591044 | ||
The general population cohort in rural south-western Uganda: a platform for communicable and non-communicable disease studies | Q36693458 | ||
Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis | Q36747893 | ||
Behavioral aspects of HIV care: adherence, depression, substance use, and HIV-transmission behaviors | Q36821663 | ||
Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme | Q36936569 | ||
Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa | Q37012911 | ||
Impact of definitions of loss to follow-up on estimates of retention, disease progression, and mortality: application to an HIV program in Mozambique | Q37127890 | ||
Impact of definitions of loss to follow-up (LTFU) in antiretroviral therapy program evaluation: variation in the definition can have an appreciable impact on estimated proportions of LTFU. | Q37138868 | ||
Non-ignorable loss to follow-up: correcting mortality estimates based on additional outcome ascertainment | Q37384915 | ||
Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures | Q37435521 | ||
Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy | Q37496608 | ||
Factors contributing to risk for cancer among HIV-infected individuals, and evidence that earlier combination antiretroviral therapy will alter this risk | Q37712406 | ||
PEPFAR, health system strengthening, and promoting sustainability and country ownership | Q38026476 | ||
HIV and metabolic, body, and bone disorders: what we know from low- and middle-income countries | Q38239435 | ||
Mental, neurological, and substance use disorders in people living with HIV/AIDS in low- and middle-income countries | Q38239436 | ||
HIV-associated renal and genitourinary comorbidities in Africa | Q38239437 | ||
Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis. | Q38464443 | ||
Investigator bias and interviewer bias: the problem of reporting systematic error in epidemiology | Q38573230 | ||
Translating global health research aims into action: the example of the ALPHA network. | Q38873076 | ||
Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration | Q38876759 | ||
Toward a systemic research agenda for addressing the joint epidemics of HIV/AIDS and noncommunicable diseases | Q39020368 | ||
Trends in retention on antiretroviral therapy in national programs in low-income and middle-income countries | Q39512357 | ||
Targeted Maximum Likelihood Estimation for Dynamic and Static Longitudinal Marginal Structural Working Models. | Q39841951 | ||
P407 | language of work or name | English | Q1860 |
P304 | page(s) | S8-16 | |
P577 | publication date | 2014-09-01 | |
P1433 | published in | Journal of Acquired Immune Deficiency Syndromes | Q6294722 |
P1476 | title | Observational research on NCDs in HIV-positive populations: conceptual and methodological considerations | |
P478 | volume | 67 Suppl 1 |
Q37037325 | Clinical Performance Validation of 4 Point-of-Care Cervical Cancer Screening Tests in HIV-Infected Women in Zambia |
Q90612746 | Comorbidity of HIV, hypertension, and diabetes and associated factors among people receiving antiretroviral therapy in Bahir Dar city, Ethiopia |
Q33777533 | Comprehensiveness of HIV care provided at global HIV treatment sites in the IeDEA consortium: 2009 and 2014. |
Q57990800 | Does mode of delivery matter for smoking cessation interventions? A meta-analysis of mHealth versus face-to-face interventions for smoking cessation among people living with HIV (Preprint) |
Q57990802 | Does mode of delivery matter for smoking cessation interventions? A meta-analysis of mHealth versus face-to-face interventions for smoking cessation among people living with HIV (Preprint) |
Q92580442 | Emergency care surveillance and emergency care registries in low-income and middle-income countries: conceptual challenges and future directions for research |
Q35750131 | Glucose Metabolism Disorders, HIV and Antiretroviral Therapy among Tanzanian Adults |
Q27010874 | HIV, tuberculosis, and noncommunicable diseases: what is known about the costs, effects, and cost-effectiveness of integrated care? |
Q26786887 | Innovations in health and demographic surveillance systems to establish the causal impacts of HIV policies |
Q92859377 | Non-communicable diseases in sub-Saharan Africa: a scoping review of large cohort studies |
Q64079045 | Noncommunicable disease burden among HIV patients in care: a national retrospective longitudinal analysis of HIV-treatment outcomes in Kenya, 2003-2013 |
Q64137244 | Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: a systematic review and meta-analysis |
Q36032285 | Population-Based Assessment of Hypertension Epidemiology and Risk Factors among HIV-Positive and General Populations in Rural Uganda |
Q37652861 | Predictors of hypertension in an urban HIV-infected population at the University of Calabar Teaching Hospital, Calabar, Nigeria |
Q52609186 | Strengthening Routine Data Systems to Track the HIV Epidemic and Guide the Response in Sub-Saharan Africa. |
Q54518743 | Strengthening of information systems and research to tackle HIV and non-communicable diseases. |
Search more.